National Health Investors - NHI Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View NHI analyst ratings or view top-rated stocks.

4 equities research analysts have issued 12 month price objectives for National Health Investors' stock. Their NHI share price forecasts range from $50.00 to $64.00. On average, they anticipate the company's stock price to reach $59.25 in the next year. This suggests a possible upside of 16.6% from the stock's current price.
View analysts price targets for NHI or view top-rated stocks among Wall Street analysts.

National Health Investors' stock was trading at $52.22 at the start of the year. Since then, NHI stock has decreased by 2.7% and is now trading at $50.80.
View the best growth stocks for 2023 here.

National Health Investors saw a drop in short interest in March. As of March 15th, there was short interest totaling 956,400 shares, a drop of 19.6% from the February 28th total of 1,190,000 shares. Based on an average daily trading volume, of 269,900 shares, the days-to-cover ratio is currently 3.5 days. Currently, 2.3% of the shares of the stock are sold short.
View National Health Investors' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our NHI earnings forecast.

National Health Investors, Inc. (NYSE:NHI) released its quarterly earnings data on Monday, May, 9th. The real estate investment trust reported $0.18 EPS for the quarter, missing the consensus estimate of $0.63 by $0.45. The real estate investment trust had revenue of $71.33 million for the quarter, compared to analysts' expectations of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 4.84% and a net margin of 23.87%. The business's quarterly revenue was down 11.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.24 earnings per share.

National Health Investors declared a quarterly dividend on Tuesday, February 21st. Stockholders of record on Friday, March 31st will be paid a dividend of $0.90 per share on Friday, May 5th. This represents a $3.60 dividend on an annualized basis and a yield of 7.09%. The ex-dividend date is Thursday, March 30th.
Read our dividend analysis for NHI.

ETFs with the largest weight of National Health Investors (NYSE:NHI) stock in their portfolio include Global X SuperDividend REIT ETF (SRET), Invesco KBW Premium Yield Equity REIT ETF (KBWY), Principal Real Estate Active Opportunities ETF (BYRE), Residential REIT Income ETF (HAUS), Hoya Capital High Dividend Yield ETF (RIET), Cambria Global Real Estate ETF (BLDG), Invesco Active U.S. Real Estate ETF (PSR) and Arrow Dow Jones Global Yield ETF (GYLD).

National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 7.24%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 244.90%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 78.26% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for NHI.

National Health Investors issued an update on its FY 2023 earnings guidance on Tuesday, February, 21st. The company provided EPS guidance of $4.24-$4.30 for the period. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

National Health Investors' stock is owned by many different institutional and retail investors. Top institutional shareholders include Macquarie Group Ltd. (2.58%), Geode Capital Management LLC (2.05%), Bank of America Corp DE (1.78%), American Century Companies Inc. (1.64%), Charles Schwab Investment Management Inc. (1.47%) and Dimensional Fund Advisors LP (1.40%). Insiders that own company stock include Robert G Adams and Robert T Webb.
View institutional ownership trends.

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NHI stock can currently be purchased for approximately $50.80.

National Health Investors (NYSE:NHI) has a market capitalization of $2.20 billion and generates $278.19 million in revenue each year. The real estate investment trust earns $66.40 million in net income (profit) each year or $1.47 on an earnings per share basis.

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The official website for the company is www.nhireit.com. The real estate investment trust can be reached via phone at (615) 890-9100, via email at investorrelations@nhireit.com, or via fax at 615-225-3030.